TY - JOUR
T1 - Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer
AU - Chow, Nan Haw
AU - Cairns, Paul
AU - Eisenberger, Claus F.
AU - Schoenberg, Mark P.
AU - Taylor, David C.
AU - Epstein, Jonathan I.
AU - Sidransky, David
PY - 2000/11/20
Y1 - 2000/11/20
N2 - Papilloma and papillary hyperplasia (PH) have been proposed to be the putative precursor lesions of papillary transitional-cell carcinoma of the urinary bladder. We examined 15 PH lesions and 4 papillomas for loss of heterozygosity (LOH) at 17 microsatellite markers on 9 chromosomal arms. Eight of 15 (53%) PHs were clonal, demonstrating LOH of at least 1 microsatellite marker. In contrast, none of the papillomas showed any genetic changes among the markers tested. In PH, chromosomal arm 9q was the most frequently lost (4/15), followed by 9p and 18q (n = 2) and, less frequently, 8p, 10q, 11p and 17p (n = 1). Furthermore, 2 hyperplastic lesions demonstrated LOH at 9q only, confirming the notion that allelic loss on chromosomal arm 9q is among the earliest events in bladder-cancer progression. In 1 patient, identical LOH patterns were observed between PH and a recurrent transitional-cell carcinoma. Our molecular data demonstrate that at least a proportion of PHs represent pre-cancerous lesions of the bladder that subsequently progress to papillary bladder cancer. Moreover, chromosomal arm 9q may harbor a tumor-suppressor gene(s) inactivated in the earliest stages of human bladder tumorigenesis. (C) 2000 Wiley-Liss, Inc.
AB - Papilloma and papillary hyperplasia (PH) have been proposed to be the putative precursor lesions of papillary transitional-cell carcinoma of the urinary bladder. We examined 15 PH lesions and 4 papillomas for loss of heterozygosity (LOH) at 17 microsatellite markers on 9 chromosomal arms. Eight of 15 (53%) PHs were clonal, demonstrating LOH of at least 1 microsatellite marker. In contrast, none of the papillomas showed any genetic changes among the markers tested. In PH, chromosomal arm 9q was the most frequently lost (4/15), followed by 9p and 18q (n = 2) and, less frequently, 8p, 10q, 11p and 17p (n = 1). Furthermore, 2 hyperplastic lesions demonstrated LOH at 9q only, confirming the notion that allelic loss on chromosomal arm 9q is among the earliest events in bladder-cancer progression. In 1 patient, identical LOH patterns were observed between PH and a recurrent transitional-cell carcinoma. Our molecular data demonstrate that at least a proportion of PHs represent pre-cancerous lesions of the bladder that subsequently progress to papillary bladder cancer. Moreover, chromosomal arm 9q may harbor a tumor-suppressor gene(s) inactivated in the earliest stages of human bladder tumorigenesis. (C) 2000 Wiley-Liss, Inc.
UR - http://www.scopus.com/inward/record.url?scp=0034693676&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034693676&partnerID=8YFLogxK
U2 - 10.1002/1097-0215(20001120)89:6<514::AID-IJC8>3.0.CO;2-H
DO - 10.1002/1097-0215(20001120)89:6<514::AID-IJC8>3.0.CO;2-H
M3 - Article
C2 - 11102896
AN - SCOPUS:0034693676
SN - 0020-7136
VL - 89
SP - 514
EP - 518
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 6
ER -